Increased facility use of mesh augmentation impacts risk of repeat prolapse repair surgery
Correlates of receiving prescription include female sex, specific physician specialty, geographic region
Desmopressin orally disintegrating tablets resulted in declines in nocturnal voids in men and women with nocturnal polyuria and mild daytime voiding dysfunction.
In a study, 28% of all incident in-hospital falls were associated with nighttime visits to the toilet.
In a study, nocturnal polyuria was present in 30% of women with overactive bladder.
Taking 2 or more drugs for hypertension is associated with a significantly higher number of nocturnal voids and higher nocturnal polyuria index, study finds.
Phase 4 trial showed that mirabegron significantly decreased incontinence episodes and micturitions compared with placebo among patients aged 65 years and older.
A study of commercially insured patients showed Asians and Hispanics were less likely than whites to undergo advanced overactive bladder treatments.
Study suggests male OAB could be associated with abnormalities in metabolic pathways of fatty acids and bile acids.
Even modestly elevated fasting plasma glucose levels and HbA1c is associated with increased odds of overactive bladder.
The ratio of visceral fat volume to total abdominal fat volume is an independent risk factor for overactive bladder, study finds.
German study revealed a 13% higher risk of falls among patients with vs without nocturia.
Of patients who had transient stress urinary incontinence after holmium laser enucleation of the prostate, 88.6% experienced resolution of the incontinence within 6 weeks after the procedure.
An expert panel developed a framework of 22 nocturia phenotypes that could set the stage for devising diagnostic and treatment pathways and stimulating research.
Among patients with detrusor underactivity, 14% of women had neuropathic causes compared with only 2% of men.
Nearly 55% of men with lower urinary tract symptoms suffer from nocturnal polyuria, according to a study conducted in Italy.
Mirabegron use for overactive bladder rose to 16% in 2016, whereas anticholinergic use decreased to 78% in 2016 from 97% in 2003, a study found.
In a phase 2 trial, treatment with an acetaminophen-ibuprofen combination was associated with a significant reduction in nocturnal voids and improved quality of life compared with placebo.
In a study, 8 mg of silodosin daily for 12 weeks was associated with a significant reduction in nocturia episodes.
A recent paper provides 8 questions to ask patients to elicit information that enables targeted treatment of nocturia.
Small study found that 2 mg of melatonin taken at bedtime did not significantly decrease the mean number of nocturia episodes vs placebo.
Women presenting with lower urinary tract symptoms cluster into 4 distinct symptom groups, according to a recent study.
Recent studies provide insight into the epidemiology of the condition and its associated complications.
Bladder hydrodistention with fulguration of Hunner lesions reduced nocturia in IC patients with or without nocturnal polyuria.
Treatment appeared to reduce fall risk among older adults.
Study confirms associations between nocturia and older age, female sex, overactive bladder, and diabetes.
Men experiencing 3 or more nocturia episodes per night had a 43% increased mortality risk in adjusted analyses.
In a study, only 5% of nocturia and nocturnal polyuria were prescribed oral desmopressin.
Clinicians tend to focus on the number of voids, but patients worry more about interrupted sleep.
Rather intermittent oxygen desaturation was associated with a 3% greater likelihood of nocturia.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)